Sphinx Trading’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Sphinx Trading’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-8,000	Closed	-$167K	–	130
2016 Q3	$167K	Buy	+8,000	New	+$92.1K	0.34%	34

Sphinx Trading's VTAE Position: Q4 2016 in Review

Sphinx Trading sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 8,000 shares — an estimated $167K sold.

Sphinx Trading first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $167K in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Sphinx Trading reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Sphinx Trading sold 8,000 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $167K.
Sphinx Trading first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
Sphinx Trading's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $167K in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Sphinx Trading's 13F filing for Q4 2016, filed 24 Jan 2017.